IDXG 0.85 (-68.52%)
US46062X3035Medical Diagnostics & ResearchDiagnostics & Research

Interpace Biosciences (IDXG) Competitor Comparison

We are evaluating the key criteria listed to compare Interpace Biosciences (IDXG) against its competitors in the Diagnostics & Research industry.

Earnings per Share - IDXG ranking 19 / 55

These are the competitors of Interpace Biosciences in the industry Diagnostics & Research ranked by earnings per share
1. Mettler-Toledo MTD
35.97
2. Thermo Fisher Scientific TMO
15.97
3. Medpace Holdings MEDP
11.42
4. Waters WAT
10.65
5. IDEXX Laboratories IDXX
10.03
6. Icon ICLR
8.95
7. Charles River Laboratories CRL
7.93
8. IQVIA Holdings IQV
7.56
9. Quest Diagnostics DGX
7.33
10. Lantheus Holdings LNTH
6.14
11. Danaher DHR
5.31
12. Laboratory Corp of America Holdings LH
5.22
13. PerkinElmer PKI
2.78
14. DexCom DXCM
1.6
15. National Research NRC
1.12
16. Syneos Health SYNH
0.7
17. Global Cord Blood CO
0.59
18. Qiagen QGEN
0.44
19. Interpace Biosciences IDXG
0.35
20. Sotera Health SHC
0.25
21. Ortho Clinical Diagnostics Holdings OCDX
0
22. RadNet RDNT
-0.07
23. Neogen NEOG
-0.1
24. Enzo Biochem ENZ
-0.19
25. Olink Holding OLK
-0.27
26. Biodesix BDSX
-0.32
27. MaxCyte MXCT
-0.34
28. Anixa Biosciences ANIX
-0.39
29. NeoGenomics NEO
-0.48
30. Psychemedics PMD
-0.51
31. Bioventus BVS
-0.59
32. Neuronetics STIM
-0.89
33. Exagen XGN
-0.91
34. bioAffinity Technologies BIAF
-0.94
35. Sera Prognostics SERA
-0.99
36. Exact Sciences EXAS
-1.16
37. Co-Diagnostics CODX
-1.22
38. Myriad Genetics MYGN
-1.28
39. Aspira Womens Health AWH
-1.41
40. MDxHealth MDXH
-1.41
41. Pacific Biosciences of California PACB
-1.46
42. DarioHealth DRIO
-1.68
43. Personalis PSNL
-1.73
44. Natera NTRA
-1.75
45. Precipio PRPO
-1.81
46. Heska HSKA
-1.92
47. Organovo Holdings ONVO
-2.16
48. Trinity Biotech TRIB
-2.57
49. CareDx CDNA
-2.65
50. Twist Bioscience TWST
-3.48
51. Prenetics Global PRE
-3.73
52. Inotiv NOTV
-4.19
53. Guardant Health GH
-4.29
54. Fulgent Genetics FLGT
-5.52
55. Illumina ILMN
-9.76

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.